Yixintang Pharmaceutical Group Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 9,238.762 million compared to CNY 7,661.374 million a year ago. Operating income was CNY 745.273 million compared to CNY 587.533 million a year ago. Net income was CNY 604.138 million compared to CNY 484.090 million a year ago. Basic earnings per share from continuing operations was CNY 1.0641 compared to CNY 0.8526 a year ago. Diluted earnings per share from continuing operations was CNY 1.0597 compared to CNY 0.8495 a year ago.